[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344897-105":59,"doc-detail-344897-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-and-clinical-validation-of-helicase-like-transcription-factor-as-a-biomarker-for-hepatocellular-carcinoma","Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma","","Immune checkpoint inhibitors (ICIs) have reshaped treatment for advanced cancers, yet many patients fail to benefit and dependable predictive biomarkers remain scarce. This study examines the immunological relevance of helicase-like transcription factor (HLTF) in hepatocellular carcinoma (HCC). HLTF was elevated across cancers, particularly in HCC, and higher HLTF linked to advanced stage, worse grade, TP53 mutations, and lymph node metastasis, with poorer overall survival, disease-specific survival, and progression-free interval. HLTF protein and transcription were higher in HCC tissues, and immune infiltration analyses showed an inverse relationship between HLTF and CD8+ T cell infiltration despite HLTF enrichment in CD8+ T cells. Nonresponders also showed greater HLTF than responders, supporting HLTF as a prognostic biomarker potentially reflecting reduced ICI effectiveness, pending validation in larger cohorts.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-and-clinical-validation-of-helicase-like-transcription-factor-as-a-biomarker-for-hepatocellular-carcinoma/344897/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-and-clinical-validation-of-helicase-like-transcription-factor-as-a-biomarker-for-hepatocellular-carcinoma/344897.png","ImageObject",300,407,{"name":92,"@type":93},"Ava Thompson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-08","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on HLTF in HCC?","Question",{"text":112,"@type":113},"The study investigates the immunological relevance of helicase-like transcription factor (HLTF) and evaluates its potential role as a biomarker in hepatocellular carcinoma treated with immune checkpoint inhibitors (ICIs).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does HLTF expression relate to clinical features and prognosis in HCC?",{"text":117,"@type":113},"Higher HLTF expression correlates with advanced tumor stage, higher histological grade, TP53 mutations, and lymph node metastasis, and it is associated with poorer overall survival, disease-specific survival, and progression-free interval.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune infiltration pattern was observed between HLTF and CD8+ T cells?",{"text":121,"@type":113},"Immune infiltration analysis showed an inverse association between HLTF expression and CD8+ T cell infiltration, while HLTF was enriched within CD8+ T cells themselves, with clear differences between HLTF-high and HLTF-low subgroups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344897,1791255165,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1649267921044,"https://us-avatar.wpscdn.com/avatar/1800007509477c92dfb?_k=1786009248482753345","Ni etal. BMC Cancer (2026) 26:321 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15652-9](https://doi.org/10.1186/s12885-026-15652-9)  \nRESEARCH Open Access  \nIntegrated and clinical validation of helicase- like transcription factor as a biomarker for hepatocellular carcinoma  \nZhiyu Ni1, Junpeng Gu1, Qingyue Qiu1, Yang Li1, Zhen Tian2, Guoping Liu1, Jie Mei3*, Jiayue Yang1* and Li Sun4*  \nAbstract  \nImmune checkpoint inhibitors (ICIs) have reshaped the treatment landscape for advanced cancers; however, a substantial proportion of patients fail to benefit from ICI therapy, and reliable predictive biomarkers remain limited. This study aimed to investigate the immunological relevance of helicase-like transcription factor (HLTF) and its potential therapeutic implications in hepatocellular carcinoma (HCC) .  \nHLTF expression was elevated across multiple cancer types, with particularly high levels observed in HCC. Increased HLTF expression was significantly associated with advanced tumor stage, higher histological grade, TP53 mutations, and lymph node metastasis. Moreover, high HLTF expression correlated with poorer overall survival, disease-specific survival, and progression-free interval in patients with HCC, indicating its potential value as a prognostic biomarker. Consistent with data from the Human Protein Atlas, HLTF protein expression was 74. 51% higher in HCC tissues than in adjacent non-tumor tissues, and a similar pattern was observed at the transcriptional level. Immune infiltration analysis revealed a negative association between HLTF expression and CD8⁺ T cell infiltration, despite notable HLTF enrichment within CD8⁺ T cells themselves. Clear differences in pDC/CD8+ T cells were observed between HLTF-high and HLTF-low subgroups, further supporting an inverse relationship between HLTF and CD8⁺ T cells in HCC TMA cohorts. In addition, we observed that tumor tissues from nonresponders displayed greater levels of HLTF compared to those from responders in our cohort.  \nTaken together, our study points out that HLTF acts as a critical marker that dwindles the effectiveness of ICIs in HCC sufferers. More trials with large numbers of patients are imperative to validate its application as a beneficial biomarker for ICIs.  \nKeywords Helicase-like transcription factor, Hepatocellular carcinoma, Immune checkpoint inhibitors, CD8+ T cells, Immunotherapy responses  \n*Correspondence:  \nJie Mei [meijie1996@njmu.edu.cn](meijie1996@njmu.edu.cn)[ ](meijie1996@njmu.edu.cn)Jiayue Yang [yangjiayue@njmu.edu.cn](yangjiayue@njmu.edu.cn)[ ](yangjiayue@njmu.edu.cn)Li Sun [sunli192025@163.com](sunli192025@163.com)  \n1Department of Endocrinology, Wuxi Medical Center, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Nanjing Medical University, No. 299 Qingyang Road, Wuxi 214023, China  \n2Department of Medical Laboratory Sciences, Wuxi Medical Center, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Nanjing Medical University, No. 299 Qingyang Road, Wuxi 214023, China  \n3The First Clinical Medicine College, Nanjing Medical University, Nanjing, Jiangsu 210029, PR China  \n4Department of Hepatobiliary Surgery, Wuxi Medical Center, The Affiliated Wuxi People’s Hospital of Nanjing Medical University, Nanjing Medical University, No. 299 Qingyang Road, Wuxi 214023, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons li","cbCailyqLg8QhEfY","https://ap.wps.com/l/cbCailyqLg8QhEfY","pdf",7702877,13,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main purpose of the study on HLTF in HCC?\",\"answer\":\"The study investigates the immunological relevance of helicase-like transcription factor (HLTF) and evaluates its potential role as a biomarker in hepatocellular carcinoma treated with immune checkpoint inhibitors (ICIs).\"},{\"question\":\"How does HLTF expression relate to clinical features and prognosis in HCC?\",\"answer\":\"Higher HLTF expression correlates with advanced tumor stage, higher histological grade, TP53 mutations, and lymph node metastasis, and it is associated with poorer overall survival, disease-specific survival, and progression-free interval.\"},{\"question\":\"What immune infiltration pattern was observed between HLTF and CD8+ T cells?\",\"answer\":\"Immune infiltration analysis showed an inverse association between HLTF expression and CD8+ T cell infiltration, while HLTF was enriched within CD8+ T cells themselves, with clear differences between HLTF-high and HLTF-low subgroups.\"}]","Integrated and clinical validation of helicase-like transcription factor as a biomarker for hepatocellular carcinoma | PDF",1790055671,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21701373d0c0015de118f537f7eaa7fe.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/57e3bdcab57c583cc1fd57f0632a300e.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8cb96facb2d407ec4dbae6f53dce6536.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65a60015470d36c3f28832e4db80b582.webp",980,1306]